We're buying the dip in a stock after an expectations reset

Jim Cramer's Charitable Trust said it would buy 40 Boeing shares at roughly $173.23, lifting its holding to 660 shares and portfolio weighting to about 3% from 2.75%. The purchase follows a 10% share decline after Boeing pushed its roughly $10 billion free-cash-flow target from 2028 to 2029; Cramer views the reset as making expectations more achievable and cites improved visibility and progress on certification. Boeing's commercial backlog is $612 billion, and the article says deliveries of the newly certified Max 7 and Max 10 are expected to begin next year.

Analysis

The reset may reduce the bar, but it does not itself establish that Boeing can convert deliveries into cash. The key mechanism is working capital: a faster production ramp can absorb cash through inventory, rework and supplier payments before customer handovers release it. Certification progress is therefore only an input; delivery cadence, quality escapes and inventory movement are the proof points. The backlog supports visibility, not near-term earnings or cash conversion.

Over 1–3 months, watch delivery data, production-rate updates and any further quality or certification disruptions. Over 6–18 months, the test is whether commercial production scales without renewed rework and whether defense-program spending crowds out commercial investment or delays cash generation. The Navy program could add durable demand, but development and capital requirements make contract value a poor proxy for free cash flow; verify milestone economics and spending disclosures.

Contrarian angle: investors may be treating the later cash-flow date as the whole story, while the larger uncertainty is whether Boeing can sustain a ramp without another operational setback. Conversely, if delivery and quality metrics improve, a conservative outlook may create room for positive revisions. Airbus could benefit from any Boeing execution slippage, while aerospace suppliers face volatility if Boeing’s ramp is repeatedly adjusted. The bullish thesis is falsified by renewed delivery/quality setbacks, worsening inventory or capex, or management pushing out the cash-flow target again.

Key Decisions for Investors

• For an existing underweight, consider a small, staged BA addition rather than chasing a sharp rebound; make subsequent adds conditional on delivery and quality data confirming the ramp.
• Do not underwrite the backlog as cash flow. Track quarterly deliveries, inventory and working-capital movements, capex, and any change to the multiyear free-cash-flow timetable.
• Keep the position risk-defined: reduce or reassess if production guidance is cut, quality-related disruptions recur, or cash-flow timing is pushed out again.
• Treat Airbus as a relative beneficiary to monitor—not an automatic short—if Boeing’s execution falters; verify order, delivery and market-share evidence before expressing that view.